Newcells Biotech strengthens executive and US team with key appointments

FHS
June 11, 2024
1:20 pm

Dr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor.

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment

MB-108 is an oncolytic virus designed to treat malignant glioma. Credit: meeboonstudio via Shutterstock. Mustang Bio has received orphan drug designation from the US Food

November 8, 2024

Skipping Chest-Wall Irradiation After Mastectomy in Intermediate-Risk Breast Cancer

SAN ANTONIO — Postmastectomy chest-wall irradiation (CWI) for intermediate-risk breast cancer had no impact on long-term survival, results of a large British study showed. After

December 17, 2024

High-tech imaging and VR used for mapping the brain and understanding developmental disorders

Through high-tech imaging and virtual reality, a University of South Florida medical engineering professor is creating a detailed map of the brain that can be

May 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.